Alteration of myo-inositol monophosphatase in Alzheimer's disease brains

被引：18
|
作者：
Shimohama, S
Tanino, H
Sumida, Y
Tsuda, J
Fujimoto, S
机构：
[1] Kyoto Univ, Fac Med, Dept Neurol, Sakyo Ku, Kyoto 606, Japan
[2] Kyoto Pharmaceut Univ, Dept Environm Biochem, Yamashina Ku, Kyoto 607, Japan
来源：
NEUROSCIENCE LETTERS | 1998年 / 245卷 / 03期
关键词：
myo-inositol monophosphatase; myo-inositol; phospholipid metabolism; brain; human; Alzheimer's disease;
D O I：
10.1016/S0304-3940(98)00209-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
myo-Inositol monophosphatase (E.C.3.1.3.25) catalyzes the hydrolysis of myo-inositol 1-phosphate in the presence of Mg2+ at a physiologic pH to form free myo-inositol, maintaining a supply that represents the precursor for inositol phospholipid second messenger signaling systems. In the present study the activity and protein level of myo-inositol monophosphatase were investigated in samples from normal human and Alzheimer's disease (AD) postmortem brains. The separation profile on Sephadex G-100 gel filtration chromatography revealed one major form of myo-inositol monophosphatase in crude extracts from both normal human and AD brains. In AD brains myo-inositol monophosphatase activity and its protein level were significantly higher than in control brains. The activity of myo-inositol monophosphatase per enzyme molecule was similar in control and AD brains. These results suggest that myo-inositol monophosphatase is upregulated in AD, probably reflecting compensatory mechanisms concerned with phospholipid metabolism. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
  • [1] Screening for inhibitors of human brain myo-inositol monophosphatase
    Ganzhorn, AJ
    Brunati, C
    Kugel, C
    Islam, K
    Galvan, M
    Chanal, MC
    Stefanelli, S
    Sponga, F
    Andreini, P
    Wolf, E
    Piriou, F
    Dulery, B
    Verne, J
    Lamard, M
    Wagner, J
    Danzin, C
    NEW FRONTIERS IN SCREENING FOR MICROBIAL BIOCATALYSTS, 1998, 53 : 103 - 109
  • [2] Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonates
    Ganzhorn, AJ
    Hoflack, J
    Pelton, PD
    Strasser, F
    Chanal, MC
    Piettre, SR
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) : 1865 - 1874
  • [3] Stereochemistry at phosphorus of the reaction catalyzed by myo-inositol monophosphatase
    Fauroux, CMJ
    Lee, M
    Cullis, PM
    Douglas, KT
    Gore, MG
    Freeman, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (06) : 1363 - 1373
  • [4] Phosphonocarboxylates and dicarboxylates as inhibitors of myo-inositol monophosphatase.
    Gaitonde, DY
    Gupta, A
    Lin, F
    Seybert, DW
    Harrold, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 159 - MEDI
  • [5] Biochemical and biological characterization of myo-inositol monophosphatase in Arabidopsis
    Donahue, Janet L.
    Torabinejad, Javad
    Gunesekera, Bhadra
    Gillaspy, Glenda
    FASEB JOURNAL, 2007, 21 (05): : A256 - A256
  • [6] Synthesis of arylalkylmonofluorophosphonates as myo-inositol monophosphatase ligands.
    Schmitt, L
    Cavusoglu, N
    Spiess, B
    Schlewer, G
    TETRAHEDRON LETTERS, 1998, 39 (23) : 4009 - 4012
  • [7] Spectroscopic studies of myo-inositol monophosphatase with a novel fluorescent substrate
    B B A Biomembr, 2 (259):
  • [8] Spectroscopic studies of myo-inositol monophosphatase with a novel fluorescent substrate
    Pineda, T
    Thorne, MJ
    Gore, MG
    Churchich, JE
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1292 (02): : 259 - 264
  • [9] myo-Inositol Monophosphatase: A Challenging Target for Mood Stabilising Drugs
    Miller, D. J.
    Allemann, R. K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 107 - 113
  • [10] Myo-inositol/creatine ratio correlates with the neuropathological involvement in Alzheimer's disease
    Kantarci, K
    Parisi, JE
    Dickson, DW
    Petersen, RC
    Boeve, BF
    Knopman, DS
    Edland, SD
    Smith, GE
    Ivnik, RJ
    Jack, CR
    NEUROBIOLOGY OF AGING, 2004, 25 : S372 - S372
12345